Together, it’s seductive to posit that the emergence of epi-drugs that rehabilitate genes inactivated through epigenetic mechanisms [100] hold promise for re-activating tumour-suppressing cellular programs through genes such as PTPRM, that leads to improved treatment strategies and reduction in mortality of high-risk patients. Here, PTPRM is linked to neoplasm.